Spinal Decompression Plus Nerve Graft Implantation Following TSCI
Minimizing Secondary Injury in Patient With SCI Using Expansive Duroplasty
1 other identifier
interventional
10
1 country
1
Brief Summary
This is a single-blinded (with outcome assessors blinded to treatment allocation), 12-month pilot study to evaluate of the safety, feasibility, and preliminary efficacy of dorsal myelotomy and expansive duraplasty performed either without or with autologous nerve graft implantation after acute traumatic spinal cord injury. Ten participants will be allocated to receive either DMED (n=5) or DMED + ANGI (n=5) based on a block design. Participants and assessors will be blinded to group allocation. Excess sural nerve samples will be collected for banking/analysis (may include proteomic, culturing, genomic, cellular analysis).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedStudy Start
First participant enrolled
April 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 10, 2025
December 1, 2025
2.7 years
January 28, 2024
December 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
SCIM- Spinal Cord Independence Measures vIII
The SCIM has been developed to address three specific areas of function in patients with spinal cord injuries (SCI). It looks at self-care (feeding, grooming, bathing, and dressing), respiration and sphincter management, and a patient's mobility abilities (bed and transfers and indoors/outdoors).
Day 84 through day 364
AIS (2019)
American Spinal Injury Association International standards for neurological classification of spinal cord injury Assessment
Screening through day 364
Study Arms (2)
DMED
ACTIVE COMPARATORDorsal myelotomy and expansive duraplasty (DMED) only.
DMED + ANGI
ACTIVE COMPARATORDorsal myelotomy and expansive duraplasty (DMED) and supplemental autologous nerve graft implantation (ANGI).
Interventions
Decompression of spinal cord with stabilization - posterior approach.
Implantation of nerve tissue following decompression ans stabilization.
Eligibility Criteria
You may qualify if:
- Age: = 18 years and = 80 years
- Written informed consent by patient or legal authorized representative
- No other life-threatening injury
- No evidence of sepsis
- Acute cervical or thoracic SCI with ASIA Impairment Scale grade A or B on admission
- Non-penetrating SCI at neurologic level from C2 to C8 or T1 to T12
- The ability to undergo surgical intervention including study procedures through a posterior approach within 48 hours of injury
You may not qualify if:
- Unconsciousness or other mental impairment that prevents neurological assessment within the first 48 hours
- Acute SCI with ASIA Impairment Scale grade C, D or E
- Spinal cord decompression and spinal stabilization can be safely performed through an anterior-only approach (i.e. posterior approach is not required)
- Currently involved in another non-observational SCI research study or receiving another investigational drug
- Other illness (including mental disorder) that could preclude accurate medical and neurological evaluation (at discretion of the principal investigator)
- Unable to commit to the follow-up schedule
- A recent history of regular substance abuse (illicit drugs, alcohol), which in the opinion of the investigator would interfere with the subject's participation in the study
- Any condition likely to result in the patient's death within the next 12 months
- Prisoner
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kentucky - Chandler Medical Center
Lexington, Kentucky, 40536, United States
Related Publications (1)
Al-Sharshahi Z, Wilcox JT, Darabi H, Arora H, Quintero JE, Gerhardt GA, van Horne CG, Farhadi F. Design and protocol for the decompression-plus trial: a phase 1 clinical study of dorsal myelotomy and expansive duroplasty with or without autologous nerve grafting in acute traumatic spinal cord injury. Neurosurg Rev. 2025 Jul 8;48(1):547. doi: 10.1007/s10143-025-03701-z.
PMID: 40624376DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis H Farhadi, MD, PhD
University of Kentucky Neurosurgery
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Single-blinded (with outcome assessors blinded to treatment allocation)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Neurosurgery
Study Record Dates
First Submitted
January 28, 2024
First Posted
February 6, 2024
Study Start
April 19, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 10, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share